First-lineD-Gam, Rhophylac
Anti-D Immunoglobulin
Human Rh(D) immunoglobulin
Prevents Rh alloimmunisation in RhD-negative women.
IMIV (Rhophylac)
First-line for
- Routine antenatal prophylaxis at 28 weeks
- Sensitising events in pregnancy
- Within 72 h of delivery if neonate RhD+
Mechanism
Passive antibody coats fetal RhD+ red cells in maternal circulation → cleared before they trigger active immune response.
“72 hours / 500 IU”
- Always within 72 h of event
- 500 IU IM standard UK antenatal dose
- Kleihauer test if >20 wks to size FMH
Dosing
- Routine antenatal (RAADP)
- 1500 IU IM at 28 wks OR 500 IU at 28 + 34 wks
- Sensitising event ≤20 wks
- 250 IU IM within 72 h
- Sensitising event >20 wks
- 500 IU IM + Kleihauer for top-up
- Post-delivery
- 500 IU IM if neonate RhD+, within 72 h
Contraindications
- AbsolutePatient already sensitised (anti-D antibodies present)
- CautionSevere thrombocytopenia (IM route)
Side effects
- Local injection site reaction
- Rarely anaphylaxis
- Mild fever, headache
Fetal & maternal notes
- • No fetal risk — IgG crosses placenta but at non-clinical dose.
- • Prevents haemolytic disease of fetus & newborn in future pregnancies.
Key interactions
Live vaccines (MMR, varicella)
CautionDelay 3 months after anti-D
Clinical pearls
- 💡 Never withhold for cffDNA delays >72 h.
- 💡 Document batch number in maternal notes.
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.